1-9 A-D E-G H-M N-P Q-S T-Z

ALLANTOIN;

ALLANTOIN;

 

CAS NUMBER; 97-59-6

 

EC NUMBER; 202-592-8

 

SYNOYMS; Glyoxyldiureide, 5-Ureidohydantoin; Allantoin; allantoin; 97-59-6; 5-Ureidohydantoin; Glyoxyldiureide; 1-(2,5-dioxoimidazolidin-4-yl)urea; Glyoxyldiureid; Allantol; Cordianine; Sebical; Alantan; AVC/Dienestrolcream; Urea, (2,5-dioxo-4-imidazolidinyl)-; Hydantoin, 5-ureido-; Cutemol emollient; Uniderm A; Glyoxylic diureide; (2,5-Dioxo-4-imidazolidinyl)urea; Psoralon; Septalan; Caswell No. 024; (2,5-dioxoimidazolidin-4-yl)urea; Glyoxylic(acid) diureide; 5-Ureido-2,4-imidazolidindion; NSC 7606; Ureidohydantoin; CCRIS 1958; Allantoin [USAN:BAN]; Fancol TOIN; 5-Ureidohydrantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; EPA Pesticide Chemical Code 085701; AI3-15281; NSC7606; 2,5-Dioxo-4-imidazolidinyl-urea; Allantoin (JAN/USP); EINECS 202-592-8; BRN 0102364; urea, N-(2,5-dioxo-4-imidazolidinyl)-
MLS000737882; C4H6N4O3; CHEBI:15676; 4-ureido-2,5-Imidazolidinedione; POJWUDADGALRAB-UHFFFAOYSA-N; MFCD00005260; N-(2,5-dioxoimidazolidin-4-yl)urea; DSSTox_CID_43Herpecin L; D00121; DSSTox_RID_75334; DSSTox_GSID_20043; (S)-Allantoin; N-[2,5-dioxoimidazolidin-4-yl]urea; SMR000528073; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amideSR-01000766252; allantion; Allantoinum; Allantoi; Hemocane; DL-Allantoin; HSDB 7490; Allantoin [USAN:USP:BAN:JAN]; CAS-97-59-6; Prestwick_11; NCGC00016358-01; 5-ureido-Hydantoin; Allantoin (8CI); 5-eaAoAOEO; (+/-)-Allantoin; Spectrum_001078; ACMC-209twn; Prestwick0_000002; Prestwick1_000002; Prestwick2_000002; Prestwick3_000002; Spectrum2_000219; Spectrum3_000876; Spectrum4_000716; Spectrum5_001526; bmse000437; D01HNL; AC1L18PM; AC1Q2AJ8; SCHEMBL3208; Oprea1_621175; Allantoin, 98% 250g; BSPBio_000003; BSPBio_002551; KBioGR_001271; KBioSS_001558; 5-25-15-00338 (Beilstein Handbook Reference); KSC679I2B; MLS002473300; Allantoin, analytical standard; Bio-0219; DivK1c_000281; SPECTRUM1500801; SPBio_000237; SPBio_001924; BPBio1_000005; CHEMBL593429; 5-Ureido-2,4-imidazolidindione; DTXSID3020043
CTK5H9420; HMS500O03; KBio1_000281; KBio2_001558; KBio2_004126; KBio2_006694; KBio3_002051; Allantoin, >=98.0% (N); MolPort-001-779-876; NINDS_000281; Urea,5-dioxo-4-imidazolidinyl)-; HMS1568A05; HMS1921I10; HMS2092K16; HMS2095A05; HMS2268N08; Pharmakon1600-01500801; component of Skin-balm (Salt/Mix); HY-N0543; NSC-7606; 2,5-Imidazolidinedione, 4-ureido-; Tox21_110395; Tox21_202087; Tox21_302912; ANW-43029; BBL027508; CCG-39781; NSC757792; SBB003997; STL373778; AKOS000120642; AKOS016038547Tox21_110395_1; CS-7741; LS-7181; MCULE-1008326286; NSC-757792; RL06095; RTR-038622; SDCCGMLS-0066595.P001; 1-(2,5-Dioxoimidazolidin-4-yl);urea; IDI1_000281; KS-0000005S; Allantoin, p.a., 98.5-101.0%; N-(2,5-Dioxo-4-imidazolidinyl)urea #; NCGC00094854-01; NCGC00094854-02; NCGC00094854-03; NCGC00094854-04; NCGC00094854-05; NCGC00094854-07; NCGC00256403-01; NCGC00259636-01; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; 4CN-0784; 5377-33-3; AC-11040; AK-77679; AN-24454; AS-13865; H736; NCI60_041675; SC-18051; N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea; SBI-0051759.P002; KB-212681; ST2408512; TR-038622; A0211; AB00052307; BG01500390; FT-0604592; ST50308144; C01551; J10470; M-5668; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); AB00052307_11; I05-0376; J-522839; SR-01000766252-2; SR-01000766252-3; SR-01000766252-4
W-100104; I14-13401; Allantoin, European Pharmacopoeia (EP) Reference Standard; A999F0D6-0285-41D9-A6BA-B705987B663C; Allantoin, United States Pharmacopeia (USP) Reference Standard; Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material; Ao>>u(1/4)a paragraph signthorn-micro feminineA Ie-2,4- paragraph signthornI feminine; 37305-69-4; 5-Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea; 58308-55-7; Allantoin; Herpecin L; Herpecin-L; HerpecinL; Sebical; Woun'dres; 5-Ureidohydantoin, Glyoxylic(acid) diureide; (2,5-DIOXO-4-IMIDAZOLIDINYL) - UREA; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; GLYOXYLDIUREID; GLYOXYLDIUREIDE; GLYOXYLIC DIUREIDE; UREA, (2,5-DIOXO-4-IMIDAZOLIDINYL) -; UREA, (2,5DIOXO4IMIDAZOLIDINYL) ; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; AI3-15281; (±)-Allantoin; (±)-Allantoin; 1-(2,5-Dioxo-4-imidazolidinyl)harnstoff [German] [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urea [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urée [French] [ACD/IUPAC Name]; 1-(2,5-Dioxoimidazolidin-4-yl)harnstoff; 1-(2,5-dioxoimidazolidin-4-yl)urea; 2,5-Dioxo-4-imidazolidinyl-urea; 202-592-8 [EINECS]; 344S277G0Z; 39669-95-9 [RN]; 4H-imidazole-2,5-diol, 4-[(hydroxyiminomethyl)amino]-4-ureido-2,5-Imidazolidinedione; 5-Ureido-2,4-imidazolidindion; 5-ureido-Hydantoin; 97-59-6 [RN]; Allantoin [BAN] [JAN] [USAN] [USP] [Wiki]; Allantoin (8CI); DL-Allantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; UNII:344S277G0Z; Urea, (2,5-dioxo-4-imidazolidinyl)-; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); Urea, N-(2,5-dioxo-4-imidazolidinyl)- [ACD/Index Name]; 5-Ureidohydrantoin; Fancol TOIN; (2,5-diketoimidazolidin-4-yl)urea; (2,5-dioxo-4-imidazolidinyl)-urea; (2,5-Dioxo-4-imidazolidinyl)urea; (2,5-dioxoimidazolidin-4-yl)urea; (2,5-Dioxo-imidazolidin-4-yl)-urea; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; [97-59-6]; 2,5-dioxoimidazolidin-4-ylurea; 2,5-Imidazolidinedione, 4-ureido-; 5-Ureido-2,4-imidazolidindione; 5-Ureido-2,4-imidazolidinedione; Actinac; Alantan; Allantoi; allantoin 98%; Allantoin CTFAallantoin standard; allantoin, ???; allantoin, 98%; allantoin, powder; Allantoinum; Allantol; Alloxantin [Wiki]; Alphosyl; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; AVC/Dienestrolcream; c4h6n4o3; Cordianin; Cutemol emollient; Dermalex; DL-ALLANTOIN-5-13C,1-15N; Glyoxyldiureid; Glyoxylic diureide; Glyoxylic(acid) diureide; Hemocane; Hydantoin, 5-ureido-; MFCD00005260 [MDL number]; N-(2,5-dioxoimidazolidin-4-yl)urea; Paxyl [Wiki]; Pharmakon1600-01500801; ProClin 300; PsoralonS-allantoin; Sebical; Septalan; Uniderm A; Urea, (2, 5-dioxo-4-imidazolidinyl)-; Ureidohydantoin.; YT1600000; ??? [Chinese]; (2,5-Dioxo-4-imidazolidinyl)urea2,5-Dioxo-4-imidazolidinyl-urea; 4-ureido-2,5-imidazolidinedione; 5-Ureido-2,4-imidazolidindione; 5-Ureidohydantoin; 5-ureidohydantoin; glyoxyldiureide; N-(2,5-Dioxo-4-imidazolidinyl)urea; InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11); POJWUDADGALRAB-UHFFFAOYSA-N; Urea, (2,5-dioxo-4-imidazolidinyl)-; 1-(2,5-dioxoimidazolidin-4-yl)urea; Urea, (2,5-dioxo-4-imidazolidinyl)-; Allantol; AVC/Dienestrolcream; Cordianine; Glyoxyldiureid; Glyoxyldiureide; Hydantoin, 5-ureido-; Sebical; 5-Ureidohydantoin; 2,5-Dioxo-4-imidazolidinyl-urea; Alantan; Glyoxylic diureide; 5-Ureidohydrantoin; Fancol TOIN; Psoralon; Septalan; 2,5-Imidazolidinedione, 4-ureido-; NSC 7606; Urea, N-(2,5-dioxo-4-imidazolidinyl)-; Glyoxyldiureide, 5-Ureidohydantoin; Allantoin; allantoin; 97-59-6; 5-Ureidohydantoin; Glyoxyldiureide; 1-(2,5-dioxoimidazolidin-4-yl)urea; Glyoxyldiureid; Allantol; Cordianine; Sebical; Alantan; AVC/Dienestrolcream; Urea, (2,5-dioxo-4-imidazolidinyl)-; Hydantoin, 5-ureido-; Cutemol emollient; Uniderm A; Glyoxylic diureide; (2,5-Dioxo-4-imidazolidinyl)urea; Psoralon; Septalan; Caswell No. 024; (2,5-dioxoimidazolidin-4-yl)urea; Glyoxylic(acid) diureide; 5-Ureido-2,4-imidazolidindion; NSC 7606; Ureidohydantoin; CCRIS 1958; Allantoin [USAN:BAN]; Fancol TOIN; 5-Ureidohydrantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; EPA Pesticide Chemical Code 085701; AI3-15281; NSC7606; 2,5-Dioxo-4-imidazolidinyl-urea; Allantoin (JAN/USP); EINECS 202-592-8; BRN 0102364; urea, N-(2,5-dioxo-4-imidazolidinyl)-; MLS000737882; C4H6N4O3; CHEBI:15676; 4-ureido-2,5-Imidazolidinedione; POJWUDADGALRAB-UHFFFAOYSA-N; MFCD00005260; N-(2,5-dioxoimidazolidin-4-yl)urea; DSSTox_CID_43; Herpecin L; D00121; DSSTox_RID_75334; DSSTox_GSID_20043; (S)-Allantoin; N-[2,5-dioxoimidazolidin-4-yl]urea; SMR000528073; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; SR-01000766252; allantion; Allantoinum; Allantoi; Hemocane; DL-Allantoin; HSDB 7490; Allantoin [USAN:USP:BAN:JAN]; CAS-97-59-6; Prestwick_11; NCGC00016358-01; 5-ureido-Hydantoin; Allantoin (8CI); 5-eaAoAOEO; (+/-)-Allantoin; Spectrum_001078; ACMC-209twn; Prestwick0_000002; Prestwick1_000002; Prestwick2_000002; Prestwick3_000002; Spectrum2_000219; Spectrum3_000876; Spectrum4_000716; Spectrum5_001526; bmse000437; D01HNL; AC1L18PM; AC1Q2AJ8; SCHEMBL3208; Oprea1_621175; Allantoin, 98% 250g; BSPBio_000003; BSPBio_002551; KBioGR_001271; KBioSS_001558; 5-25-15-00338 (Beilstein Handbook Reference); KSC679I2B; MLS002473300; Allantoin, analytical standard; Bio-0219; DivK1c_000281; SPECTRUM1500801; SPBio_000237; SPBio_001924; BPBio1_000005; CHEMBL593429; 5-Ureido-2,4-imidazolidindione; DTXSID3020043; CTK5H9420; HMS500O03; KBio1_000281; KBio2_001558; KBio2_004126; KBio2_006694; KBio3_002051; Allantoin, >=98.0% (N); MolPort-001-779-876; NINDS_000281; Urea,5-dioxo-4-imidazolidinyl)-; HMS1568A05; HMS1921I10; HMS2092K16; HMS2095A05; HMS2268N08; Pharmakon1600-01500801; component of Skin-balm (Salt/Mix); HY-N0543; NSC-7606; 2,5-Imidazolidinedione, 4-ureido-; Tox21_110395; Tox21_202087; Tox21_302912; ANW-43029; BBL027508; CCG-39781; NSC757792; SBB003997; STL373778; AKOS000120642; AKOS016038547; Tox21_110395_1; CS-7741; LS-7181; MCULE-1008326286; NSC-757792; RL06095; RTR-038622; SDCCGMLS-0066595.P001; 1-(2,5-Dioxoimidazolidin-4-yl);urea; IDI1_000281; KS-0000005S; Allantoin, p.a., 98.5-101.0%; N-(2,5-Dioxo-4-imidazolidinyl)urea #; NCGC00094854-01; NCGC00094854-02; NCGC00094854-03; NCGC00094854-04; NCGC00094854-05; NCGC00094854-07; NCGC00256403-01; NCGC00259636-01; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; 4CN-0784; 5377-33-3; AC-11040; AK-77679; AN-24454; AS-13865; H736; NCI60_041675; SC-18051; N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea; SBI-0051759.P002; KB-212681; ST2408512; TR-038622; A0211; AB00052307; BG01500390; FT-0604592; ST50308144; C01551; J10470; M-5668; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); AB00052307_11; I05-0376; J-522839; SR-01000766252-2; SR-01000766252-3; SR-01000766252-4; W-100104; I14-13401; Allantoin, European Pharmacopoeia (EP) Reference Standard; A999F0D6-0285-41D9-A6BA-B705987B663C; Allantoin, United States Pharmacopeia (USP) Reference Standard; Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material; Ao>>u(1/4)a paragraph signthorn-micro feminineA Ie-2,4- paragraph signthornI feminine; 37305-69-4; 5-Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea; 58308-55-7; Allantoin; Herpecin L; Herpecin-L; HerpecinL; Sebical; Woun'dres; 5-Ureidohydantoin, Glyoxylic(acid) diureide; (2,5-DIOXO-4-IMIDAZOLIDINYL) - UREA; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; GLYOXYLDIUREID; GLYOXYLDIUREIDE; GLYOXYLIC DIUREIDE; UREA, (2,5-DIOXO-4-IMIDAZOLIDINYL) -; UREA, (2,5DIOXO4IMIDAZOLIDINYL) ; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; AI3-15281; (±)-Allantoin; (±)-Allantoin; 1-(2,5-Dioxo-4-imidazolidinyl)harnstoff [German] [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urea [ACD/IUPAC Name]; 1-(2,5-Dioxo-4-imidazolidinyl)urée [French] [ACD/IUPAC Name]; 1-(2,5-Dioxoimidazolidin-4-yl)harnstoff; 1-(2,5-dioxoimidazolidin-4-yl)urea; 2,5-Dioxo-4-imidazolidinyl-urea; 202-592-8 [EINECS]; 344S277G0Z; 39669-95-9 [RN]; 4H-imidazole-2,5-diol, 4-[(hydroxyiminomethyl)amino]-; 4-ureido-2,5-Imidazolidinedione; 5-Ureido-2,4-imidazolidindion; 5-ureido-Hydantoin; 97-59-6 [RN]; Allantoin [BAN] [JAN] [USAN] [USP] [Wiki]; Allantoin (8CI); DL-Allantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; UNII:344S277G0Z; Urea, (2,5-dioxo-4-imidazolidinyl)-; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); Urea, N-(2,5-dioxo-4-imidazolidinyl)- [ACD/Index Name]; 5-Ureidohydrantoin; Fancol TOIN; (2,5-diketoimidazolidin-4-yl)urea; (2,5-dioxo-4-imidazolidinyl)-urea; (2,5-Dioxo-4-imidazolidinyl)urea; (2,5-dioxoimidazolidin-4-yl)urea; (2,5-Dioxo-imidazolidin-4-yl)-urea; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; [97-59-6]; 2,5-dioxoimidazolidin-4-ylurea; 2,5-Imidazolidinedione, 4-ureido-; 5-Ureido-2,4-imidazolidindione; 5-Ureido-2,4-imidazolidinedione; Actinac; Alantan; Allantoi; allantoin 98%; Allantoin CTFA; allantoin standard; allantoin, ???; allantoin, 98%; allantoin, powder; Allantoinum; Allantol; Alloxantin [Wiki]; Alphosyl; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; AVC/Dienestrolcream; c4h6n4o3; Cordianin; Cutemol emollient; Dermalex; DL-ALLANTOIN-5-13C,1-15N; Glyoxyldiureid; Glyoxylic diureide; Glyoxylic(acid) diureide; Hemocane; Hydantoin, 5-ureido-; MFCD00005260 [MDL number]; N-(2,5-dioxoimidazolidin-4-yl)urea; Paxyl [Wiki]; Pharmakon1600-01500801; ProClin 300; Psoralon; S-allantoin; Sebical; Septalan; Uniderm A; Urea, (2, 5-dioxo-4-imidazolidinyl)-; Ureidohydantoin.; YT1600000; ??? [Chinese]; (2,5-Dioxo-4-imidazolidinyl)urea; 2,5-Dioxo-4-imidazolidinyl-urea; 4-ureido-2,5-imidazolidinedione; 5-Ureido-2,4-imidazolidindione; 5-Ureidohydantoin; 5-ureidohydantoin; glyoxyldiureide; N-(2,5-Dioxo-4-imidazolidinyl)urea; InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11); POJWUDADGALRAB-UHFFFAOYSA-N; Urea, (2,5-dioxo-4-imidazolidinyl)-; 1-(2,5-dioxoimidazolidin-4-yl)urea; Urea, (2,5-dioxo-4-imidazolidinyl)-; Allantol; AVC/Dienestrolcream; Cordianine; Glyoxyldiureid; Glyoxyldiureide; Hydantoin, 5-ureido-; Sebical; 5-Ureidohydantoin; 2,5-Dioxo-4-imidazolidinyl-urea; Alantan; Glyoxylic diureide; 5-Ureidohydrantoin; Fancol TOIN; Psoralon; Septalan; 2,5-Imidazolidinedione, 4-ureido-; NSC 7606; Urea, N-(2,5-dioxo-4-imidazolidinyl)-; allantoine>; allantoın; allantoıne; allan toın; allan toine; allan toın; allan toin; ALLANTOİN; ALLANTOIN; ALLAN TOIN; ALLAN TOİNE; ALLAN TOINE; ALLAN TOIN; ALLANTOIN ; ALLANTOİN; allantoin; 97-59-6; 5-Ureidohydantoin; Glyoxyldiureide; 1-(2,5-dioxoimidazolidin-4-yl)urea; Glyoxyldiureid; Allantol; Cordianine; Sebical Alantan; AVC/Dienestrolcream; Urea, (2,5-dioxo-4-imidazolidinyl)-; Hydantoin, 5-ureido-; Cutemol emollient; Uniderm A; Glyoxylic diureide; (2,5-Dioxo-4-imidazolidinyl)urea; Psoralon; Septalan; Caswell No. 024; (2,5-dioxoimidazolidin-4-yl)urea; Glyoxylic(acid) diureide; 5-Ureido-2,4-imidazolidindion; NSC 7606; Ureidohydantoin; Allantoi; CCRIS 1958; Allantoin [USAN:BAN]; Fancol TOIN; 5-Ureidohydrantoin; N-(2,5-Dioxo-4-imidazolidinyl)urea; EPA Pesticide Chemical Code 085701; AI3-15281; NSC7606; 2,5-Dioxo-4-imidazolidinyl-urea; Allantoin (JAN/USP); EINECS 202-592-8; BRN 0102364; urea, N-(2,5-dioxo-4-imidazolidinyl)-; MLS000737882; C4H6N4O3; CHEBI:15676; 4-ureido-2,5-Imidazolidinedione; POJWUDADGALRAB-UHFFFAOYSA-N; MFCD00005260; N-(2,5-dioxoimidazolidin-4-yl)urea; DSSTox_CID_43; Herpecin L; D00121; DSSTox_RID_75334; DSSTox_GSID_20043; (S)-Allantoin; N-[2,5-dioxoimidazolidin-4-yl]urea; 5377-33-3; SMR000528073; amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide; allantion; Allantoinum; Hemocane; DL-Allantoin; Allantoin CTFA; HSDB 7490; Allantoin [USAN:USP:BAN:JAN]; CAS-97-59-6; Prestwick_11; NCGC00016358-01; 5-ureido-Hydantoin; Allantoin (8CI); 5-eaAoAOEO; (+/-)-Allantoin; Spectrum_001078; ACMC-209twn; Prestwick0_000002; Prestwick1_000002; Prestwick2_000002; Prestwick3_000002; Spectrum2_000219; Spectrum3_000876; Spectrum4_000716; Spectrum5_001526; bmse000437; D01HNL; AC1L18PM; AC1Q2AJ8; SCHEMBL3208; Oprea1_621175; Allantoin, 98% 250g; BSPBio_000003; BSPBio_002551; KBioGR_001271; KBioSS_001558; 5-25-15-00338 (Beilstein Handbook Reference); RSC679I2B; MLS002473300; Allantoin, analytical standard; Bio-0219; DivK1c_000281; SPECTRUM1500801; SPBio_000237; SPBio_001924; BPBio1_000005; CHEMBL593429; 5-Ureido-2,4-imidazolidindione; DTXSID3020043; CTK5H9420; HMS500O03; KBio1_000281; KBio2_001558; KBio2_004126; KBio2_006694; KBio3_002051; Allantoin, >=98.0% (N); MolPort-001-779-876; NINDS_000281; Urea,5-dioxo-4-imidazolidinyl)-; HMS1568A05; HMS1921I10; HMS2092K16; HMS2095A05; HMS2268N08; Pharmakon1600-01500801; component of Skin-balm (Salt/Mix); HY-N0543; NSC-7606; 2,5-Imidazolidinedione, 4-ureido-; Tox21_110395; Tox21_202087; Tox21_302912; ANW-43029; BBL027508; CCG-39781; NSC757792; SBB003997; STL373778; AKOS000120642; AKOS016038547; Tox21_110395_1; CS-7741; LS-7181; MCULE-1008326286; NSC-757792; RL06095; RTR-038622; SDCCGMLS-0066595.P001; 1-(2,5-Dioxoimidazolidin-4-yl);urea; IDI1_000281; KS-0000005S; Allantoin, p.a., 98.5-101.0%; N-(2,5-Dioxo-4-imidazolidinyl)urea #; NCGC00094854-01; NCGC00094854-02; NCGC00094854-03; NCGC00094854-04; NCGC00094854-05; NCGC00094854-07; NCGC00256403-01; NCGC00259636-01; (RS)-(2,5-dioxoimidazolidin-4-yl)urea; 4CN-0784; AC-11040; AK-77679; AN-24454; AS-13865; BT000187; H736; HE033953; HE331747; HE420345; HE420346; NCI60_041675; SC-18051; N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea; SBI-0051759.P002; KB-212681; ST2408512; TR-038622; A0211; AB00052307; FT-0604592; ST50308144; C01551; J10470; M-5668; Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI); AB00052307_11; SR-01000766252; I05-0376; J-522839; SR-01000766252-2; W-100104; I14-13401; Allantoin, European Pharmacopoeia (EP) Reference Standard; A999F0D6-0285-41D9-A6BA-B705987B663C; Allantoin, United States Pharmacopeia (USP) Reference Standard; Allantoin, pharmaceutical secondary standard; traceable to USP and PhEur; Ao>>u(1/4)a paragraph signthorn-micro feminineA Ie-2,4- paragraph signthornI feminine; 37305-69-5-; Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea; 58308-55-7; Glyoxyldiureide; 5-Ureidohydantoin; (2,5-DIOXO-4-IMIDAZOLIDINYL) - UREA; (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; GLYOXYLDIUREID; GLYOXYLDIUREIDE; GLYOXYLIC DIUREIDE; UREA, (2,5-DIOXO-4-IMIDAZOLIDINYL) -; UREA, (2,5DIOXO4IMIDAZOLIDINYL); (2,5-DIOXO-4-IMIDAZOLIDINYL) UREA; 5-UREIDOHYDANTOIN; 102364; C4H6N4O3; POJWUDADGALRAB-UHFFFAOYSA-N; ?98%; 5-Ureidohydantoin; Glyoxylic(acid) diureide; MFCD00005260; 202-592-8; Allantoin, ?98.0% (N); Allantoin, analytical standard; Allantoin, European Pharmacopoeia (EP) Reference Standard; Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material; Allantoin, United States Pharmacopeia (USP) Reference Standard; 5-Ureidohydantoin; Glyoxylic(acid) diureide; analytical standard; InChI KeyPOJWUDADGALRAB-UHFFFAOYSA-N; assay?98.0% (HPLC); 5397; ChEBI:15678; ChEMBL:CHEMBL1230080; PDB-CCD:3AL[PDBj]; 3DMET:B00428; NIKKAJI:J732.396D; FormulaC4H6N4O3; Exact mass 158.044; Mol weight158.1154; ALLANTON; ALLANTONE; ALLANTOINE; ALLANTOIN; allantoıne; allantoine; allantoin; allantoın; allanton; allantan; allantaina; allantaına; ALLONTOİN; allontoın; allontoin; ALLONTOYIN; ALLONTOYİN; allontoyın; allontoyin; (2,5-Dioxo-4-imidazolidinyl) urea; GLYOXYLDIUREIDE; glyoxyldıureıde; Glyoxyldiureide; gloksıldıure; gloksildiüre; GLOKSILDIURE; GLOKSİLDİÜRE; 5 UREIDOHYDANTOIN; 5 UREİDOHYDANTOİN; 5 ureıdohydantoın; 5 üreidohydantoin; 5-Ureidohydantoin; ALANTOİNE; ALANTOİN; ALLANTOİN; ALANTOİN; ALLANTaOIN; ALANTOIN; ALLANTOİNE; ALLANTONE; allantoine; allantoin; alantoin; alantoın; allantoine; allantoıne; alantoine; allantoine; alantoın; alantoın; allantoın; allantoin; allantoyin; alantoyin; allantoyıne; allantoyın; allantoyin; allantoine; allantoyın; alantoyın; allatoyıin; allantoyın; allantoıne; alantoyin; alantoyine; alantoyine;

 

 

 


Allantoin;

Cildi yenileyici ve koruyucu etkisi kanıtlanmış doğal bir aktiftir.
ABD Gıda ve İlaç Dairesi (FDA) Allantoin'i Kategori 1 (güvenli ve etkili) de cilt koruyucu olarak sınıflandırmıştır.
Bir kozmetik hammadde olarak Allantoin'in çalışma mekanizması hala net olarak anlaşılamamış olmasına rağmen, değeri ve etkinliği yapılan birçok in-vitro ve in-vivo testlerle desteklenmiştir
Allantoin %0,3 kullanıldığında bile oldukça etkili bir anti inflamatuardır. Hem etkisi hem de ekonomik olması nedeniyle, reçetesiz topikal formülasyonlarda ve kozmetik ürünlerde yaygın olarak kullanılır.
Allantoin, cildin doğal yenilenmesi desteklemek, tahriş olmasını önlemek, nem tutma kapasitesini geliştirmek ve cildi yumuşatmak için kullanılır.


Açıklama

Allantoin insan vücuduna endojen olan ve aynı zamanda insan diyetlerinin normal bir bileşeni olan [FDA Label] bir maddedir. Sağlıklı insan gönüllülerinde, ortalama plazma plazma konsantrasyonu yaklaşık 2-3 mg / l'dir. Egzersiz sırasında, plazma allantoin konsantrasyonu hızla iki kat artar ve yüksek kalır [FDA Label]. İnsan kasında, bu egzersiz sırasında urat allantoine oksitlenir [FDA Label]. Kaslardaki allantoin konsantrasyonu, kısa süreli aşırı bisiklet egzersizinden [FDA Label] hemen sonra yaklaşık 5000 ug / kg ila yaklaşık 16000 µg / kg dinlenme değerinden artar.

Daha spesifik olarak, allantoin, ürik asitten üretilen bir glioksilik asit diüritidir. Çoğu organizmada önemli bir metabolik ara madde. Allantoin, OTC kozmetik ürünlerinde ve ağız hijyeni ürünleri, şampuanlar, rujlar, anti-akne ürünleri, güneş bakım ürünleri ve arındırıcı losyonlar gibi diğer ticari ürünlerde bulunur. Allantoin ayrıca bazı çalışmalarda yara iyileşme sürecini iyileştirdiğini göstermiştir.


Nedir ?

Allantoin beyaz bir tozdur. Karakafes ve at kestanesi gibi bitkilerde ve çoğu memelinin idrarında bulunabilir. Kozmetik ve cilt bakım ürünlerinde en çok kullanılan tip, üre ve glioksilik asittir.

Ne yapar ?

Allantoin anti-tahriş edici, yatıştırıcı ve iyileştirici özelliklere sahiptir: tahrişleri yatıştırır, ölü deri hücrelerinin üst katmanlarını dökmeye yardımcı olur ve sağlıklı dokunun büyümesini destekler. Bu yüzden yaraların, egzamaların, sedeflerin, yanıkların ve diğer cilt hastalıklarının tedavisinde etkilidir.

 

Kullanımları

Allantoin, yara, carbuncles, yanıklar ve sunburns, scalds, akne ve cilt döküntüleri, impetigo, sedef, egzama, çatlak ve sıyrıkların tedavisi için yararlıdır.

Allantoin yüz gençleştirme ürünlerinde kullanılan yaşlanma karşıtı bir maddedir. Cilt bakım ürünlerinin ortak bir maddesidir. Tahriş olmuş cildin yatıştırılmasında etkilidir, hücre rejenerasyonunu uyarır ve kuru cildi nemlendirir.

Allantoinin etkililiğini ve yararlarını değerlendirirken, çeşitli yüz temizleyicileri, akne ürünleri, tonerler, güneş kremleri, nemlendiriciler ve diğer özel cilt bakım ürünlerinde kullanılır.

Allantoin türevleri aşağıdaki gibi kişisel bakım ürünleri getirdi:

• Deodorantlar ve antiperspirantlar

• Tıraş ürünleri

• Cilt-büzücü losyonlar

• Sivilce Karşıtı

• Ayak preparatları ürünleri

• Veteriner preparatları ürünleri

• Toz alma tozu ve kremi

• Saç bakım ürünleri

• Anti-inflamatuar ürünler

 

 


Allantoin;

The skin is a natural actor proven to be refreshing and protective.
The US Food and Drug Administration (FDA) classified Allantoin as Category 1 (safe and effective) as a skin protector.
Although the working mechanism of Allantoin as a cosmetic raw material is still unclear, value and efficacy have been supported by many in-vitro and in-vivo tests
Even when allantoin is used at 0.3%, it is a highly effective anti-inflammatory. Because it is both effective and economical, it is widely used in over-the-counter topical formulations and cosmetic products.
Allantoin is used to promote natural renewal of the skin, to prevent irritation, to improve moisture retention capacity and to soften the skin.


Description

Allantoin is a substance that is endogenous to the human body and also found as a normal component of human diets [FDA Label]. In healthy human volunteers, the mean plasma concentration of allantoin is about 2-3 mg/l. During exercise, the plasma allantoin concentration rapidly increases about two fold and remains elevated [FDA Label]. In human muscle, urate is oxidized to allantoin during such exercise [FDA Label]. The concentration of allantoin in muscles increases from a resting value of about 5000 ug/kg to about 16000 ug/kg immediately after short-term exhaustive cycling exercise [FDA Label].

More specifically, allantoin is a diureide of glyoxylic acid that is produced from uric acid. It is a major metabolic intermediate in most organisms. Allantoin is found in OTC cosmetic products and other commercial products such as oral hygiene products, in shampoos, lipsticks, anti-acne products, sun care products, and clarifying lotions . Allantoin has also demonstrated to ameliorate the wound healing process in some studies

What it is ?

Allantoin is a white powder. It can be found in plants, like comfrey and horse chestnut, and in the urine of most mammals. The type that is most commonly used in cosmetics and skincare products though derives from urea and glyoxylic acid.

What it does ?

Allantoin has anti-irritant, soothing and healing properties: it calms down irritations, helps shed the upper layers of dead skin cells and promotes the growth of healthy tissue. That's why it's effective at treating wounds,eczema, psoriasis, burns and other skin conditions


Uses

Allantoin is useful for the treatment of wound, carbuncles, burns and sunburns, scalds, acne and skin eruptions, impetigo, psoriasis, eczema, fissures and abrasions.

Allantoin is an anti-aging ingredient used in facial rejuvenation products. It is a common ingredient of skin care products. It is proven effective in soothing irritated skin, stimulates cell regeneration and moisturizes dry skin.

In harnessing the effectiveness and benefits of allantoin, it is used in various facial cleaners, acne products, toners, sunscreens, moisturizers, and other specialty skin care products.

The derivatives of allantoin brought about personal care products such as follows:

• Deodorants and antiperspirants

• Shaving products

• Skin-astringent lotions

• Anti-Acne

• Foot preparations products

• Veterinary preparations products

• Dusting powder and cream

• Hair care products

• Anti-inflammatory products

 

 

Acar Kimya A.Ş. © 2015 Tüm Hakları Saklıdır.